These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34388358)

  • 1. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
    Hogan CA; Jassem AN; Sbihi H; Joffres Y; Tyson JR; Noftall K; Taylor M; Lee T; Fjell C; Wilmer A; Galbraith J; Romney MG; Henry B; Krajden M; Galanis E; Prystajecky N; Hoang LMN
    Emerg Infect Dis; 2021 Nov; 27(11):2802-2809. PubMed ID: 34388358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada.
    Matic N; Lowe CF; Ritchie G; Stefanovic A; Lawson T; Jang W; Young M; Dong W; Brumme ZL; Brumme CJ; Leung V; Romney MG
    Emerg Infect Dis; 2021 Jun; 27(6):1673-1676. PubMed ID: 33784237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
    Skowronski DM; Setayeshgar S; Zou M; Prystajecky N; Tyson JR; Galanis E; Naus M; Patrick DM; Sbihi H; El Adam S; Henry B; Hoang LMN; Sadarangani M; Jassem AN; Krajden M
    Clin Infect Dis; 2022 Apr; 74(7):1158-1165. PubMed ID: 34244723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.
    Chan YLE; Irvine MA; Prystajecky N; Sbihi H; Taylor M; Joffres Y; Schertzer A; Rose C; Dyson L; Hill EM; Tildesley M; Tyson JR; Hoang LMN; Galanis E
    Emerg Infect Dis; 2023 Oct; 29(10):1999-2007. PubMed ID: 37640374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of SARS-CoV-2 Variants on Réunion Island, France, 2021.
    Mercier A; Wilkinson DA; Lebarbenchon C; Mavingui P; Yemadje-Menudier L
    Emerg Infect Dis; 2022 Apr; 28(4):895-898. PubMed ID: 35319434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021.
    Park AK; Kim IH; Man Kim H; Lee H; Lee NJ; Kim JA; Woo S; Lee CY; Lee J; Oh SJ; Rhee J; Yoo CK; Kim EJ
    Emerg Infect Dis; 2022 Feb; 28(2):415-419. PubMed ID: 35076365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens.
    Kuchinski KS; Nguyen J; Lee TD; Hickman R; Jassem AN; Hoang LMN; Prystajecky NA; Tyson JR
    Int J Infect Dis; 2022 Jan; 114():51-54. PubMed ID: 34757201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.
    Kehoe AD; Mallhi AK; Barton CR; Martin HM; Turner CM; Hua X; Kwok KO; Chowell G; Fung IC
    Emerg Infect Dis; 2024 May; 30(5):956-967. PubMed ID: 38666622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
    Skowronski DM; Febriani Y; Ouakki M; Setayeshgar S; El Adam S; Zou M; Talbot D; Prystajecky N; Tyson JR; Gilca R; Brousseau N; Deceuninck G; Galanis E; Fjell CD; Sbihi H; Fortin E; Barkati S; Sauvageau C; Naus M; Patrick DM; Henry B; Hoang LMN; De Wals P; Garenc C; Carignan A; Drolet M; Jassem AN; Sadarangani M; Brisson M; Krajden M; De Serres G
    Clin Infect Dis; 2022 Nov; 75(11):1980-1992. PubMed ID: 35438175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community.
    Hirotsu Y; Omata M
    Infect Genet Evol; 2021 Nov; 95():105088. PubMed ID: 34560289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan.
    Moser W; Fahal MAH; Abualas E; Bedri S; Elsir MT; Mohamed MFERO; Mahmoud AB; Ahmad AII; Adam MA; Altalib S; DafaAllah OA; Hmed SA; Azman AS; Ciglenecki I; Gignoux E; González A; Mwongera C; Miranda MA
    Emerg Infect Dis; 2022 May; 28(5):1026-1030. PubMed ID: 35450565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Infection in a Hippopotamus, Hanoi, Vietnam.
    Bui VN; Dao TD; Tran LH; Vu TT; Nguyen TH; Nguyen GH; Tran KVD; Nguyen HX; Bui AN; Unger F; Nguyen-Viet H; Lee HS
    Emerg Infect Dis; 2023 Mar; 29(3):658-661. PubMed ID: 36823956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological analysis of the emergence and disappearance of the SARS-CoV-2 Kappa variant within a region of British Columbia, Canada.
    Ghafari C; Benusic M; Prystajecky N; Sbihi H; Kamelian K; Hoang L
    Can Commun Dis Rep; 2022 Jan; 48(1):22-26. PubMed ID: 35273466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
    Fillâtre P; Dufour MJ; Behillil S; Vatan R; Reusse P; Gabellec A; Velmans N; Montagne C; Geffroy Du Coudret S; Droumaguet E; Merour V; Enouf V; Buzelé R; Valence M; Guillotel E; Gagnière B; Baidaliuk A; Zhukova A; Tourdjman M; Thibault V; Grolhier C; Pronier C; Lescure FX; Simon-Loriere E; Costagliola D; Van Der Werf S; Tattevin P; Massart N
    Clin Microbiol Infect; 2022 Feb; 28(2):298.e9-298.e15. PubMed ID: 34627988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genomics and epidemiology of SARS-CoV-2 lineage].
    Sukegawa S; Takeuchi H
    Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in a remote First Nations community in British Columbia, Canada: an outbreak report.
    Smith CR; Enns C; Cutfeet D; Alfred S; James N; Lindbeck J; Russell S
    CMAJ Open; 2021; 9(4):E1073-E1079. PubMed ID: 34848548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SARS-CoV-2 variants: the pandemics within the pandemic.
    Boehm E; Kronig I; Neher RA; Eckerle I; Vetter P; Kaiser L;
    Clin Microbiol Infect; 2021 Aug; 27(8):1109-1117. PubMed ID: 34015535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.